FdaApplication
BLA 761508
Identifiers
- fda_app_no: BLA761508
Properties
| Property | Value |
|---|---|
| applicant_name | Regeneron Pharmaceuticals, Inc. |
| application_type | BLA |
| approval_date | 2026-08-19 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| PASATRU | GARETOSMAB-GRTS | 300MG/5ML (60MG/ML) | Injection |
1 product